Ayşegül Yılmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ayşegül Yılmaz has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Özdemir
University of Health Sciences, Turkey
1 shared publication - Ali Baykan
Pediatric Cardiology Department Medical Faculty Mustafa Eraslan Children Hospital Erciyes University Melikgazi Kayseri 38030 Turkey erciyes.edu.tr
1 shared publication - Alper Dogan
Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey
1 shared publication - Alper Ozcan
Erciyes University Faculty of Medicine, Department of Pediatrics Hematology and Oncology, Kayseri, Türkiye
1 shared publication - Arife Canpolat1 shared publication
- Ayten Güleç
Department of Pediatrics, Division of Pediatric Neurology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
1 shared publication
Latest Publications
- 27 May 2025
- Published by Academician Publishing
- p. 593-598
Genetik Hastalıklar İçin Kullanılan Tanı Testleri
- 27 May 2025
- Published by Academician Publishing
- p. 593-598
Genetik Hastalıklar İçin Kullanılan Tanı Testleri
- 27 May 2025
- Published by Academician Publishing
- p. 583-592
Sık Görülen Kromozomal Hastalıklar
- Open Access
- 27 May 2025
- Published by Academician Publishing
Canpolat-Karakükcü-Dursun-Poyrazoğlu Pediatride Temel Bilgiler
- 27 May 2025
- Published by Academician Publishing
Open AccessCanpolat-Karakükcü-Dursun-Poyrazoğlu Pediatride Temel Bilgiler
- 13 April 2023
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (7) , 1814-1825
The clinical phenotype of Koolen‐de Vries syndrome in Turkish patients and literature review
Koolen‐de Vries syndrome (KdVS) is a rare multisystemic disorder caused by a microdeletion on chromosome 17q21.31 including KANSL1 gene or intragenic pathogenic variants in KANSL1 gene. Here, we describe the clinical and genetic spectrum of eight Turkish children with KdVS due to a de novo 17q21.31 deletion, and report on several rare/new conditions. Eight patients from unrelated families aged between 17 months and 19 years enrolled in this study. All patients evaluated by a clinical geneticist, and the clinical diagnosis were confirmed by molecular karyotyping. KdVS patients had some common distinctive facial features. All patients had neuromotor retardation, and speech and language delay. Epilepsy, structural brain anomalies, ocular, ectodermal, and musculoskeletal findings, and friendly personality were remarkable in more than half of the patients. Hypertension, hypothyroidism, celiac disease, and postaxial polydactyly were among the rare/new conditions. Our study contributes to the clinical spectrum of patients with KdVS, while also provide a review by comparing them with previous cohort studies.
- 13 April 2023
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (7) , 1814-1825
The clinical phenotype of Koolen‐de Vries syndrome in Turkish patients and literature review
Koolen‐de Vries syndrome (KdVS) is a rare multisystemic disorder caused by a microdeletion on chromosome 17q21.31 including KANSL1 gene or intragenic pathogenic variants in KANSL1 gene. Here, we describe the clinical and genetic spectrum of eight Turkish children with KdVS due to a de novo 17q21.31 deletion, and report on several rare/new conditions. Eight patients from unrelated families aged between 17 months and 19 years enrolled in this study. All patients evaluated by a clinical geneticist, and the clinical diagnosis were confirmed by molecular karyotyping. KdVS patients had some common distinctive facial features. All patients had neuromotor retardation, and speech and language delay. Epilepsy, structural brain anomalies, ocular, ectodermal, and musculoskeletal findings, and friendly personality were remarkable in more than half of the patients. Hypertension, hypothyroidism, celiac disease, and postaxial polydactyly were among the rare/new conditions. Our study contributes to the clinical spectrum of patients with KdVS, while also provide a review by comparing them with previous cohort studies.
- 18 January 2023
- Published by Academician Publishing
- p. 661-674
Nörogenetik Hastalıklarda Klinik Yaklaşım ve Yönetim
Genetik bozukluklar; zihinsel yetersizlik ve yaygın gelişimsel gerilik gibi nörolojik tabloların etyolojisinde merkezi bir rol oynamaktadır. Hastaların klinik değerlendirmesi, ayrıntılı öykü ve muayene ile başlayıp, kromozom analizi ve mikrodizin gibi geleneksel yöntemlerden tüm ekzom dizileme gibi ileri moleküler tekniklere kadar uzanan kapsamlı bir tanısal süreci gerektirir. Down, Patau ve Klinefelter sendromları gibi çeşitli kromozomal anomaliler ve mikrodelesyon/duplikasyon sendromları, farklı fenotipik özelliklerle karakterize olup, tanısal süreçte çok disiplinli bir yaklaşımı zorunlu kılar. Güncel moleküler genetik analizler, önceki yöntemlerle tanımlanamayan vakaların aydınlatılmasında kritik bir öneme sahiptir. Genetic disorders play a central role in the etiology of neurological conditions such as intellectual disability and global developmental delay. Clinical assessment requires a comprehensive diagnostic process starting with detailed history and physical examination, followed by advanced molecular techniques ranging from traditional chromosomal analysis to whole-exome sequencing. Various chromosomal anomalies, such as Down, Patau, and Klinefelter syndromes, along with diverse microdeletion and duplication syndromes, present unique phenotypic characteristics that demand a multidisciplinary diagnostic approach. Modern molecular genetic tools are increasingly vital for identifying the underlying genetic causes in cases that remain undiagnosed by standard testing.
- 18 January 2023
- Published by Academician Publishing
- p. 661-674
Nörogenetik Hastalıklarda Klinik Yaklaşım ve Yönetim
Genetik bozukluklar; zihinsel yetersizlik ve yaygın gelişimsel gerilik gibi nörolojik tabloların etyolojisinde merkezi bir rol oynamaktadır. Hastaların klinik değerlendirmesi, ayrıntılı öykü ve muayene ile başlayıp, kromozom analizi ve mikrodizin gibi geleneksel yöntemlerden tüm ekzom dizileme gibi ileri moleküler tekniklere kadar uzanan kapsamlı bir tanısal süreci gerektirir. Down, Patau ve Klinefelter sendromları gibi çeşitli kromozomal anomaliler ve mikrodelesyon/duplikasyon sendromları, farklı fenotipik özelliklerle karakterize olup, tanısal süreçte çok disiplinli bir yaklaşımı zorunlu kılar. Güncel moleküler genetik analizler, önceki yöntemlerle tanımlanamayan vakaların aydınlatılmasında kritik bir öneme sahiptir. Genetic disorders play a central role in the etiology of neurological conditions such as intellectual disability and global developmental delay. Clinical assessment requires a comprehensive diagnostic process starting with detailed history and physical examination, followed by advanced molecular techniques ranging from traditional chromosomal analysis to whole-exome sequencing. Various chromosomal anomalies, such as Down, Patau, and Klinefelter syndromes, along with diverse microdeletion and duplication syndromes, present unique phenotypic characteristics that demand a multidisciplinary diagnostic approach. Modern molecular genetic tools are increasingly vital for identifying the underlying genetic causes in cases that remain undiagnosed by standard testing.